Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Irene Rius Ruiz
Observed names:
Irene Rius,
Irene Rius-Ruiz,
Rius Ruiz, Irene
Institution:
Vall d'Hebron Institute of Oncology
Observed institutions:
Aarhus University,
Centro de Investigación Biomédica en Red de Cáncer,
Vall d'Hebron Institute of Oncology
ORCID:
0000-0002-6097-7572
Observed ORCID:
0000-0002-6097-7572
OpenAlex ID:
A5047346706
p95HER2–T cell bispecific antibody for breast cancer treatment
2018
·
Irene Rius Ruiz
, Rocio Vicario
, et al.
·
Science Translational Medicine
·
86
LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer
2022
·
Iván Pérez-Núñez
, Catalina Rozalén
, et al.
·
Nature Cancer
·
69
PDF
Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation
2021
·
Enrique J. Arenas
, Alex Martínez-Sabadell
, et al.
·
Nature Communications
·
64
PDF
Novel principles of gamma-retroviral insertional transcription activation in murine leukemia virus-induced end-stage tumors
2014
·
Martin Sokol
, Matthias Wabl
, et al.
·
Retrovirology
·
27
PDF
The target antigen determines the mechanism of acquired resistance to T cell-based therapies
2022
·
Alex Martínez-Sabadell
, Beatriz Morancho
, et al.
·
Cell Reports
·
16
PDF
Generation of chimeric antigen receptor T cells targeting p95HER2 in solid tumors
2024
·
Macarena Román Alonso
, Ariadna Grinyó-Escuer
, et al.
·
Nature Communications
·
13
Three-dimensional cell culture of chimeric antigen receptor T cells originated from peripheral blood mononuclear cells towards cellular therapies
2023
·
Eduardo Pérez del Río
, Macarena Román Alonso
, et al.
·
Cytotherapy
·
4
PDF
Humanized CAR T cells targeting p95HER2
2022
·
Macarena Román
, Irene Rius-Ruiz
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
3
PDF
Abstract 1690: JAK2 downmodulation leads to interferon gamma deficient response and resistance to immunotherapy in breast cancer
2021
·
Enrique Javier Arenas Lahuerta
, Alex Martínez-Sabadell
, et al.
·
Cancer Research
·
1
Abstract 2044: The target antigen determines the mechanism of acquired resistance to T cell based therapies
2022
·
Alex Martínez-Sabadell
, Beatriz Morancho
, et al.
·
Cancer Research
Abstract 3970: Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation
2022
·
Alex Martínez-Sabadell
, Enrique J. Arenas
, et al.
·
Cancer Research
Abstract 1859: The antigen target is critical in the mechanism of resistance to T-cell based therapies
2021
·
Alex Martínez-Sabadell
, Enrique J. Arenas
, et al.
·
Cancer Research
Abstract 5570: Identification of novel mechanisms of resistance against the redirection of T-cell effector function for cancer therapy
2020
·
Enrique Javier Arenas Lahuerta
, Alex Martínez-Sabadell
, et al.
·
Cancer Research
Abstract 5573: Mechanism of resistance against T cell bispecific antibodies depends on targeted antigen
2020
·
Alex Martínez-Sabadell
, Enrique J. Arenas
, et al.
·
Cancer Research
Abstract LB-292: p95HER2-T cell bispecific antibody for breast cancer treatment
2018
·
Rocío Vicario
, Irene Rius Ruiz
, et al.
·
Cancer Research
Show more works
View as search
Works count:
16
Citation count:
283
H-index:
6
I10-index:
6
Year
Topic
Type